Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
聚乙二醇干扰素λ治疗COVID-19门诊患者：一项II期安慰剂对照随机试验
期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(20)30566-X
Feld, Jordan J; Kandel, Christopher; Biondi, Mia J; Kozak, Robert A; Zahoor, Muhammad Atif; Lemieux, Camille; Borgia, Sergio M; Boggild, Andrea K; Powis, Jeff; McCready, Janine; Tan, Darrell H S; Chan, Tiffany; Coburn, Bryan; Kumar, Deepali; Humar, Atul; Chan, Adrienne; O'Neil, Braden; Noureldin, Seham; Booth, Joshua; Hong, Rachel; Smookler, David; Aleyadeh, Wesam; Patel, Anjali; Barber, Bethany; Casey, Julia; Hiebert, Ryan; Mistry, Henna; Choong, Ingrid; Hislop, Colin; Santer, Deanna M; Lorne Tyrrell, D; Glenn, Jeffrey S; Gehring, Adam J; Janssen, Harry L A; Hansen, Bettina E
